Article Listing - King makes $1.2B public takeover bid for Alpharma, despite Board's rejection

US MARKET FOR FLU TREATMENTS

17 February 1992

The proliferation of flu remedies currently appearing on US drugstore shelves is more a product of marketing than medical breakthroughs,...

US GENERIC DRUG MARKET TO 1995

17 February 1992

The US market for generic drugs will more than double from a value of $5.5 billion in 1991 to reach...

GENZYME PRODUCES CFTR PROTEIN VIA MILK

17 February 1992

Genzyme Corp has announced that its researchers have developed the first genetically-engineered mice to produce in their milk a membrane...

HAFSLUND NYCOMED 46% OPERATING PROFIT JUMP

17 February 1992

Norwegian company Haflsund Nycomed reported a massive 46% rise in total operating profits for 1991, reaching 1.58 billion Norwegian kroner...

US OTC DRUGMAKERS A TAKEOVER TARGET

17 February 1992

The value of over-the-counter medicine franchises will continue to rise and as a result smaller OTC drugmakers (such as Carter...

MOROCCO BANS GLAFENINE

10 February 1992

Morocco is the latest country to ban marketing of Roussel Uclaf's glafenine-based analgesic products Adalgur, Glifanan and Myantal. A...

H2 BLOCKERS FOR RHINITIS?

10 February 1992

The possibility that histamine H2 receptor blockers may be useful as a treatment for individuals with rhinitis has been raised...

GERMAN DRUG CONSUMPTION

10 February 1992

Klaus Stuerzbecher, president of the German federation of pharmacists, the ABDA, has said that a new ABDA study shows that,...

APPROVAL SETBACK FOR US BIOSCIENCE

10 February 1992

The US Food and Drug Administra-tion's Oncologic Drugs Advisory Committee has declined to recommend marketing approval of US Biosci-ence Inc's...

CORTEX IN STROKE TREATMENT JV

10 February 1992

Two US biotechnology companies have agreed to develop potential treatments for stroke and other acute degenerative brain disorders. Cortex Pharmaceuticals...

Showing 94761-94770 of 95329 articles